Pharmaceuticals in Turkey industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
The Turkish pharmaceuticals market registered revenue of $8.9 billion in 2023, representing a compound annual growth rate (CAGR) of 6.9% between 2018 and 2023.
Turkey acquired a share of 2.4% of the European pharmaceuticals market in 2023.
Scope
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Turkey
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Turkey
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Turkey pharmaceuticals market with five year forecasts
Reasons to Buy
What was the size of the Turkey pharmaceuticals market by value in 2023?
What will be the size of the Turkey pharmaceuticals market in 2028?
What factors are affecting the strength of competition in the Turkey pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up Turkey's pharmaceuticals market?
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the recent developments in the market?